Hématologie, the journal of the French Haematology Society (SFH), provides an invaluable link between all the biomedical disciplines involved in haematology. It has established its position as a major French-language journal aimed at both clinicians and researchers.
Haematology is a rapidly developing area and our journal keeps pace with the changes. With this new format, the Editorial Board wanted to offer readers an even greater focus on clinical matters, a larger board and new sections including "Residents' Corner" and "How do I treat…"
Hématologie presents articles written by top oncology and haematology authors. As well as the six current issues, readers have access to reports from all the big national and international congresses.
Some articles of the journal are published in English, you will find them in the English e-section.
AIMS AND SCOPES
Hématologie is the official organ of the French Society of Hematology. It publishes review articles in all areas of hematology, written by the best specialists in these fields. These reviews are generally solicited by members of the editorial board, but direct submissions are welcome. Regardless of the mode of submission, manuscripts are peer-reviewed and revisions are, in most cases, requested before publication. The journal also provides a forum for interns and junior faculty to comment on recent major publications or papers from international haematology meetings. The journal also publishes the proceedings of the annual meeting of the French Society of Hematology. Articles may be submitted in French or English.
It is intended for hematologists, as well as students in training (DES, AFSA, etc.). It covers all hematological diseases, both malignant and benign. Hématologie (Éditions John Libbey Eurotext) publishes, in French or in English, reviews, anatomical cases, forums for ethical reflection, recommendations from learned societies and cooperative groups, as well as short reports on current literature in haematology. It also features "Residents' Corner" and "How I treat", which give the floor to hematology residents and senior specialists respectively. Articles are most often solicited by the editorial staff, but any proposal for collaboration will be considered with interest.
Here you will find all John Libbey Eurotext (JLE) policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.
- Editorial policy
- Peer review policy
- Commercial policy
- Ethical rules - Links of interest, human and animal rights, informed patient consent
- Corrections, retractions and expressions of reservations
- Copyright, Open Access and data sharing
Instructions to authors
Failure to follow these instructions may result in a delay in the publication of your manuscript.
For assistance, please send your questions to the editorial office: firstname.lastname@example.org
Hôpital Saint-Louis, Paris, France
The other members of the editorial board are mentioned on the dedicated page.
Clinical haematologists or biologists, haematology researchers, haematology interns
The journal Hematology is referenced in EMBASE/Excerpta Medical/Scopus/Google Scholar
The journal uses a double-blind review process.Each article is initially evaluated by the Editor-in-Chief and Associate Editors to ensure that the content is appropriate for the journal.If the article is found to be appropriate, it is anonymised and sent to at least two independent expert reviewers to assess its scientific quality. The editor-in-chief makes the final decision as to whether to accept or reject the article. For more information on the evaluation of articles: https://www.jle.com/en/peer-review-policy
Haematology is an independent peer-reviewed journal and its distribution is linked to subscriptions. The journal is a member of the Syndicat de la presse et de l'édition des professions de santé.
The publisher John Libbey Eurotext adheres to the charter for continuing medical education through writing of the National Union of the Medical Press and Health Professions (SNPM) and respects its rules (charter available on request).
Case original articles
Haematology regularly publishes case reports and, exceptionally, articles presenting clinical research results. Both types of manuscripts must comply with the rules given below.
Protection of research study participants
The journal requires that each research article submitted include a statement that the study has obtained ethical approval (or a statement that it was not required and why), including the name of the ethics committee(s) or institutional review board(s).
Authors must ensure that the conduct and publication of research involving human data is in accordance with the Declaration of Helsinki as revised in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/).
All authors must have approval to conduct research from an independent local, regional or national human protection committee (e.g. ethics committees, institutional review board). If there is any doubt as to whether the research was conducted in accordance with the Declaration of Helsinki, the authors should explain the rationale for their approach and demonstrate that the local, regional or national review board has explicitly approved the questionable aspects of the study. Approval by a responsible review board does not preclude the writers from having their own judgement as to whether the conduct of the research was appropriate.
In the case of animal experiments, the authors should indicate whether national and institutional guidelines for the care and use of laboratory animals were followed.
Patient consent and confidentiality
Any manuscript containing personal data of patients must comply with the AVR and ensure anonymisation, consent and confidentiality of the patient. The journal reserves the right to refuse to publish any manuscript that does not comply with the requirements set out in this policy.
See our page detailing the ethical rules followed by the journal: https://www.jle.com/en/ethical-rules
Links of interest
We ask authors to carefully consider the editorial and presentation requirements of the articles. We attach particular importance to the declaration of links of interest, which directly engages the responsibility of authors.
All authors' interests in the article, including the absence of interests, must be declared on the cover page of the manuscript.
Links of interest will also be the subject of a declaration to be completed and signed at the time of proofreading. They will be mentioned at the end of the article after receipt of this declaration.
In case of non-response, the article will be noted: Links of interest: [First name and surname of the author] has not declared any links of interest in relation to the article.
Defining the role of authors and contributors
Authorship of a biomedical work brings recognition and has important academic, social and financial implications. Authorship also implies responsibility and accountability for published research. The aim is to ensure not only that any contributor who has made a substantial intellectual contribution to a manuscript is recognised as an author, but also that any contributor listed as an author understands that he or she must take responsibility and accountability for what is published.
For a detailed view of the journal's editorial policy: https://www.jle.com/en/editorial-policy
Publishing contract and author remuneration
Journal articles and articles in the "How I treat" section are paid on a per-page basis. We thank the authors for their contribution to the journal.
Authors undertake that in preparing their manuscript they have not received any payment or benefit in kind from an industrial company and that no industrial company has requested a correction of their text. Otherwise, a contract will have to be signed between the sponsor and the publisher (JLE) to decide on the form of the publication: supplemental issue, detachable insert or sponsored article in compliance with the rules laid down by the editorial board of the journal and the learned societies, partners of the journal. The sponsored publication will in any case be clearly indicated as such.
A publishing contract is sent by e-mail to the corresponding author after publication of the issue.
No submission or publication fees are charged to authors or their institutions. Figures are redrawn in colour and re-translated to conform to the journal's graphic standards.
The different sections
Review articles are most often solicited by the editorial board. However, the editorial board will consider any article submitted spontaneously. A review article provides an exhaustive state of the art on the announced subject, whether it is a pathology, a particular clinical situation, a diagnostic technique, a therapeutic strategy, etc. It provides a critical analysis of the subject and its implications for the health of the reader. It provides a critical analysis of the published work on the subject and the authors can propose conclusions or future research directions.
It is recommended that articles be designed in an editorial form with limited classifications (chapter, sub-chapter, etc.).
No particular format (length, organisation or style) is imposed for review articles, but the length should not exceed what is reasonably considered necessary to deal with the topic.
The bibliographical references must be sufficient to cover the subject matter exhaustively. A number of references in excess of 100 should be justified by the breadth of the subject matter.
Review articles must give a summary of their content, in French and English, as well as key words, also in French and English.
It is strongly recommended that the manuscript be supplemented with pedagogical diagrams, figures and tables to improve readability and accessibility for the non-specialist reader.
In particular, it is very welcome to include a graphical abstract.
Focus: The aim of the focus articles is to present a simple and clear overview of knowledge on a specific subject with a limited scope. These articles are most often motivated by the emergence of a strong theme, which the authors put into perspective with previously acquired data on the subject.
Focus papers should not exceed 12 typed pages (including references, diagrams, tables and their legends). A normal title, its English translation and a short title should be provided.
Each focus should include an informative French summary, translated into English, with 3-6 key words and their English translations. It may include illustrations, algorithms, tables and figures of an informative nature.
The list of references should not be exhaustive, but rather selective: 15 to 20 references, maximum 25. The headings should be short.
The main reference, if there is one, should appear in bold.
Editorials should not exceed six typed pages, with a maximum of 10 references. The editorial presents a particular, forward-looking or original view of the discipline. General topics in public health, health policy or general practice are not allowed.
News items are short texts (two or three typed pages, maximum), reporting on a recent publication in the international haematological literature. Each news item is based on a sparse bibliography: less than ten references.
The recommendations (guidelines) are provided by a learned society or a cooperative group, and are the result of a collective work carried out within the institution that produced them. They are an official document, reflecting a scientific consensus on a specific subject, and are not accompanied by any remuneration or transfer of reproduction rights.
The Residents' corner contains texts written by interns in haematology, revised and corrected by a senior doctor. The articles summarise a particular aspect of the training received as part of the specialist study diploma (DES), and are subject to the same constraints as journal articles.
How I treat is a section in which a senior doctor, whose expertise is internationally recognised, presents a particular aspect of his or her practice on which he or she is considered by the haematology community to be a reference.
How to submit articles
All authors must indicate any link of interests (financial interests, clinical trials, ad hoc interventions or family relationships) that may influence their professional judgements.
The manuscript should be sent to the journal's secretariat at: email@example.com
The title page includes :
- the title in French and English, which should be concise but informative
- the first name and surname of each author;
- the name and address of the author to whom correspondence should be addressed, including telephone number and e-mail address;
- the affiliation of each author.
- Links of interest (or lack thereof) should be notified on the front page, by name, for each author.
The abstract, provided in English and French, should provide a general understanding of the issues addressed in the article. It should give a balanced account of the different parts of the article, without going into detail about the results and data reported in the body of the article. The abstract in English can be further developed. No references should be cited in the abstract.
Immediately after the abstract, list up to 6 keywords. Avoid general terms, plurals and multiple concepts (avoid, for example, "and", "of"). Avoid abbreviations: only abbreviations well established in the field are allowed, and should be expanded. These keywords will be used for indexing purposes.
Funding and acknowledgements
Acknowledgements of individuals, grants, funds, etc. should be placed in a separate paragraph before the references, entitled "Acknowledgements".
Funding: details of all sources of funding for the work in question should be given in a separate section entitled 'Funding'. This should appear after the Acknowledgements section.
You are asked to identify the entity or entities that provided the underlying financial support for the conduct of the research and/or the preparation of the article. You should also briefly describe the role of the funder(s), if any, in (a) the design of the trial, (b) the collection, analysis and interpretation of the data, (c) the writing of the report, and (d) the decision to submit the article for publication. If the funding source(s) did not contribute, then this should be mentioned.
References are numbered in the order in which they are first mentioned in the text (Arabic numbers). They appear in the text in square brackets. References should be chosen from journals that are accessible to the widest possible audience (avoid esoteric journals) and should be based primarily on good general journals rather than on original articles. References cited only in tables or figures are numbered in a sequence established by the first identification of the table in the text. They refer only to published work (including abstracts) or work in press. Journal titles are abbreviated according to the US National Library of Medicine (annually in the January issue of Index Medicus).
If there are six or fewer authors, cite them all. If there are more than six, list the first three, followed by "et al.
Articles from periodicals
Names of authors, followed by the initials of their first names. Title of article (in original language). Name of journal abbreviated according to Index Medicus style (no punctuation after abbreviations) year; volume: first and last page of article.
- Oakland K, Guy R, Uberoi R, et al. Acute lower GI bleeding in the UK: patient characteristics, interventions and outcomes in the first nationwide audit. Gut 2018; 67 (4): 654-62.
Supplement to a periodical :
- Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan (abstract). Blood 1979; 54 (Suppl. 1): 26a.
Same presentation of the authors. Title of the book. City: name of publisher, year of publication. - Soria JC, Vignot S, Massard C, Mir O. Course in antitumor chemotherapy and medical treatment of cancer. Paris: John Libbey Eurotext, 2013.
Chapter of a book: Same presentation of the authors. Title of the article (in the original language). In: initials and names of "editors". Title of the book. City: name of publisher, year of publication: first and last page of the article.
- Rindi G, Arnold R, Kloppel G, et al. Nomenclature and classifica- tion of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (Eds.), WHO classification of tumours of the digestive system. Lyon: IARC, 2010: 13-14.
At a minimum, you should provide the full URL and the date the reference was last accessed. Any other information, if known (DOI, authors' names, dates, reference to a source publication, etc.) should also be provided.
Each table is typed in double spacing on a separate sheet. Tables are numbered (Arabic numerals) in the order of their first citation in the text. Explanations or miscellaneous notes appear below the tables.
Tables should be provided in editable format as separate Word/text documents.
PDF is not an acceptable format for tables.
Footnotes or captions are preferable to long explanatory texts. Notes should be identified by superscript letters and placed immediately below the table.
Abbreviations and acronyms used on the table are defined in the legend, and the table text should be translated if it is in English.
Figures should not be integrated into the text. Each figure is provided in electronic format. Photographs must be submitted in JPEG or TIFF format with a minimum resolution of 300 dpi. Drawings or diagrams must be submitted as Powerpoint® or Word® files. Letters, numbers or symbols must be clear and of sufficient size to make each element perfectly legible. Titles or detailed explanations are not included in the illustration.
Captions are typed double-spaced on a separate page. They should be concise but understandable without having to read the text. Abbreviations and acronyms used in the figure are defined in the legend, and the text of the figure should be translated if it is in English.
Do not provide files optimised for on-screen use (e.g. GIF, BMP, PICT, WPG), as these formats usually have too few pixels and a limited colour set.
Medicines and devices
Medicines are identified by the generic name (international non-proprietary name) without the initial capital letter. The speciality name may be mentioned in brackets with an initial capital letter, followed by the symbol ® and the name of the pharmaceutical company if the medicine is not well known. The trade name of a device is followed by the name of the manufacturer or distributor in brackets.
Abbreviations and symbols
The full term precedes the abbreviation when it first appears in the text (unless it is an international unit of measurement). Their use must be consistent and invariable throughout the article. Abbreviations are not allowed in titles, intertitles or abstracts. A complete list of abbreviations used is given on a separate sheet at the end of the manuscript. It is advisable to use the minimum number of abbreviations and never when a term is used less than 3 times.
Third party material
In the event that some of the illustrations are produced by third parties, whether or not they have already been published, the author undertakes to obtain from them all the necessary authorisations for the integration of these illustrations into the article and for their use in this form. He/she will communicate these authorisations for reproduction with his/her manuscript.
These permissions are generally issued via the website https://www.copyright.com (see the "Get permission" button available for each article). They may be subject to a fee, which is always payable by the author.
If you wish to include figures, images or extracts from previously published articles, it is your responsibility to obtain permission to do so. All material must be properly referenced and you must have the written consent of the copyright holder (this may be the publisher rather than the author). This includes your own previously published material, if you are not the copyright holder.
It is possible and even desirable to add additional material (text, photos, moving images, videos) to your article. It will be sent when the manuscript is submitted and not afterwards.
Material such as videos, for example, will be published in line with the electronic version of your article.
If additional material can only be published online, this must be clearly stated in the manuscript.
Additional material should be sent as separate file(s) and precisely described in the manuscript, to allow for proper linking. They must be named and numbered accordingly (Table S1, Figure S1, Video S1, etc.) in the manuscript and in the file name.
All files provided must be correctly named so as to refer directly to the contents of the video file.
Please provide screenshots with your files: you can choose any image from your video or animation sequence or create a separate image. These captures will allow you to customise the link to each video.
Proofs will be sent to the corresponding author by e-mail as a pdf file, together with a rights assignment agreement and a declaration of links of interest to be filled in individually by each author.
Corrections and other documents must be returned by the corresponding author within five working days of receipt of the proof, by e-mail (firstname.lastname@example.org).
If this deadline is not met, the editorial office may assume responsibility for proofreading.
The corrected proof is available online, in prepublication, less than a week after the corrections have been sent, on the publisher's website, under the heading Articles ahead of print: https://www.jle.com/en/revues/hma/aop.phtml
Offprints and copies
After the publication of the printed issue, an electronic reprint in PDF format is sent to the corresponding author by e-mail.
Printed offprints can be ordered for a fee using the form attached to the e-mail during proofreading and after publication of the journal on request to email@example.com
A free copy of the issue is sent to the corresponding author on request during proofreading.
Archiving policy and open access
Authors can disseminate their research in different ways.
For more information on content access policies, see the link to Sherpa Romeo :
In the case of open access articles, permission for (re)use by third parties is defined according to the Creative Commons user licences defined below.
Whichever publication method you choose, the journal will apply the same peer review criteria and acceptance standards.
Creative Commons Attribution - No Commercial Use - No Derivative Works (CC BY-NC-ND) Non-commercial license: allows users to distribute and copy the article, and to include it in a collective work (e.g. an anthology), provided that they credit the authors and do not alter or modify the article.
The open access publication fee for Hématologie is EUR 400 plus VAT.
John Libbey Eurotext
30A, rue Berthollet 94110 Arcueil, France
Tel: +33 (0)1 46 73 06 60 - Fax: +33 (0)1 40 84 09 99
Director of publication: Gilles Cahn
To contact our team and answer your requests, remarks and questions:
• Editor: Nicolas Bourrié
Phone: +33 (0)7 63 59 03 36
• Electronic or printed offprints: Valérie Toulgoat
Tel: +33 (0)7 63 58 96 26
• Publishing contracts and copyright: Odile Guini
Tel: +33 (0)7 63 59 03 71
• Subscriptions and marketing: Bérengère Brun
Tel: + 33 (0)7 63 59 03 20
• Classifieds: Corinne Salmon
Assistant to the Partnerships and Advertising Department
Phone: +33 (0)7 63 59 04 06
• Advertising: David Laifer
Partnerships & Advertising Department
Tel: +33 (0)7 63 59 03 94
• Supplements/Partnerships/Reprints: Noëlle Croisat
Customer Manager Partnerships/Reprints
Tel: +33 (0)7 63 59 03 68
• Congresses and scientific meetings: Valérie Berland
Congress & Product Marketing
Tel: +33 (0)7 63 59 03 21
• Reproduction rights: Anne Chevalier
Tel: +33 (0)7 63 59 03 46
Further information can be obtained from the following address
Revue Hématologie - Editorial Office
30A rue Berthollet
Tel: +33 (0)1 46 73 06 60